http://surgerybook.net/

9. Wray CJ, Kao LS, Millas SG, et al. Acute appendicitis: controversies in diagnosis and management.

Curr Probl Surg 2013;50(2):54–86.

10. Liu K, Fogg L. Use of antibiotics alone for treatment of uncomplicated acute appendicitis: a

systematic review and meta-analysis. Surgery 2011; 150(4):673–683.

11. Wilms IM, de Hoog DE, de Visser DC, et al. Appendectomy versus antibiotic treatment for acute

appendicitis. Cochrane Database Syst Rev 2011;(11):CD008359.

12. Ansaloni L, Catena F, Coccolini F, et al. Surgery versus conservative antibiotic treatment in acute

appendicitis: a systematic review and meta-analysis of randomized controlled trials. Dig Surg

2011;28(3):210–221.

13. Salminen P, Paajanen H, Rautio T, et al. Antibiotic therapy vs appendectomy for treatment of

uncomplicated acute appendicitis: the APPAC randomized clinical trial. JAMA 2015;313(23):2340–

2348.

14. Livingston E, Vons C. Treating appendicitis without surgery. JAMA 2015;313(23):2327–2328.

15. Kao LS, Boone D, Mason RJ; Evidence-Based Reviews in Surgery Group. Antibiotics vs

appendectomy for uncomplicated acute appendicitis. J Am Coll Surg 2013;216(3):501–505.

16. Ingraham AM, Cohen ME, Bilimoria KY, et al. Comparison of outcomes after laparoscopic versus

open appendectomy for acute appendicitis at 222 ACS NSQIP hospitals. Surgery 2010;148:625–635;

discussion 635–637.

17. Sauerland S, Jaschinski T, Neugebauer EA. Laparoscopic versus open surgery for suspected

appendicitis. Cochrane Database Syst Rev 2010;10:CD001546.

18. Drake FT, Mottey NE, Farrokhi ET, et al. Time to appendectomy and risk of perforation in acute

appendicitis. JAMA Surg 2014;149(8):837–844.

19. Simillis C, Symeonides P, Shorthouse AJ, et al. A meta-analysis comparing conservative treatment

versus acute appendectomy for complicated appendicitis (abscess or phlegmon). Surgery

2010;147:818–829.

20. Andersson RE, Petzold MG. Nonsurgical treatment of appendiceal abscess or phlegmon: a

systematic review and meta-analysis. Ann Surg 2007;246(5):741–748.

21. Kaminski A, Liu IL, Applebaum H, et al. Routine interval appendectomy is not justified after initial

nonoperative treatment of acute appendicitis. Arch Surg 2005;140:897–901.

22. Ein SH, Langer JC, Daneman A. Nonoperative management of pediatric ruptured appendix with

inflammatory mass or abscess: presence of an appendicolith predicts recurrent appendicitis. J

PediatrSurg 2005;40:1612–1615.

23. Demehri FR, Alam HB. Evidence-based management of common gallstone-related emergencies. J

Intensive Care Med 2016;31(1):3–13.

24. Kiewiet JJ, Leeuwenburgh MM, Bipat S, et al. A systematic review and meta-analysis of diagnostic

performance of imaging in acute cholecystitis. Radiology 2012;264(3):708–720.

25. Broderick-Villa G, Burchette RJ, Collins JC, et al. Hospitalization for acute diverticulitis does not

mandate routine elective colectomy. Arch Surg 2005;140(6):576–581.

26. Morris AM, Regenbogen SE, Hardiman KM, et al. Sigmoid diverticulitis: a systematic review. JAMA

2014;311(3):287–297.

27. Regenbogen SE, Hardiman KM, Hendren S, et al. Surgery for diverticulitis in the 21st century: a

systematic review. JAMA Surg 2014;149(3):292–303.

28. Hinchey EJ, Schaal PG, Richards GK. Treatment of perforated diverticular disease of the colon. Adv

Surg 1978;12:85–109.

29. Cirocchi R, Trastulli S, Desiderio J, et al. Treatment of Hinchey stage III–IV diverticulitis: a

systematic review and meta-analysis. Int J Colorectal Dis 2013;28(4):447–457.

30. To KB, Napolitano LM. Clostridium difficile infection: update on diagnosis, epidemiology, and

treatment strategies. Surg Infect (Larchmt) 2014;15(5):490–502.

31. Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a

systematic review. JAMA 2015;313(4):398–408.

32. Cohen SH, Gerding DN, Johnson S, et al.; Society for Healthcare Epidemiology of America;

Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection

in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the

infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431–455.

259

http://surgerybook.net/

33. Cornely OA, Crook DW, Esposito R, et al. Fidaxomicin versus vancomycin for infection with

Clostridium difficile in Europe, Canada, and the USA: a double-blind, noninferiority, randomised

controlled trial. Lancet Infect Dis 2012;12:281–289.

34. Neal MD, Alverdy JC, Hall DE, et al. Diverting loop ileostomy and colonic lavage: an alternative to

total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated

disease. Ann Surg 2011;254:423–427; discussion 423–429.

35. Rosenberg A, Steensma EA, Napolitano LM. Necrotizing pancreatitis: new definitions and a new era

in surgical management. Surg Infect (Larchmt) 2015;16(1):1–13.

36. De Waele JJ, Rello J, Anzueto A, et al. Infections and use of antibiotics in patients admitted for

severe acute pancreatitis: data from the EPIC II study. Surg Infect 2014;15:394–398.

37. van Santvoort HC, Besselink MG, Bakker OJ, et al. A stepup approach or open necrosectomy for

necrotizing pancreatitis. N Engl J Med 2010;362:1491–1502.

38. Warshaw AL. Improving the treatment of necrotizing pancreatitis—a step up. N Engl J Med

2010;362:1535–1537.

39. van Brunschot S, Fockens P, Bakker OJ, et al. Endoscopic transluminal necrosectomy in necrotising

pancreatitis: a systematic review. Surg Endosc 2014;28:1425–1438.

40. Napolitano LM. Introduction: the diagnosis and treatment of skin and soft tissue infections (SSTIs).

Surg Infect (Larchmt) 2008;9(suppl 1):s1.

41. DiNubile MJ, Lipsky BA. Complicated infections of skin and skin structures: when the infection is

more than skin deep. J Antimicrob Chemother 2004;53(suppl 2):ii37–ii50.

42. Vinh DC, Embil JM. Severe skin and soft tissue infections and associated critical illness. Curr Infect

Dis Rep 2007;9(5):415–421.

43. Napolitano LM. Severe soft tissue infections. Infect Dis Clin North Am 2009;23(3):571–591.

44.

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071185.pd45. May AK. Skin and soft tissue infections. Surg Clin North Am 2009;89(2):403–420.

46. Chan T, Yaghoubian A, Rosing D, et al. Low sensitivity of physical examination findings in

necrotizing soft tissue infection is improved with laboratory values: a prospective study. Am J Surg

2008;196(6):926–930; discussion 930.

47. Wall DB, deVirgilio C, Black S, et al. Objective criteria may assist in distinguishing necrotizing

fasciitis from non-necrotizing soft tissue infection. Am J Surg 2000;179(11):17–21.

48. Wall DB, Klein SR, Black S, et al. A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infections. J Am Coll Surg 2000;191(3):227–231.

49. Zacharias N, Velmahos GC, Salama A, et al. Diagnosis of necrotizing soft tissue infections by

computed tomography. Arch Surg 2010;145(5):452–455.

50. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate

antibiotic treatment for ventilator-associated pneumonia. Chest 2002;122:262–268.

51. Garnacho-Montero J. Impact of adequate empirical antibiotic therapy on the outcome of patients

admitted to the intensive care unit with sepsis. Crit Care Med 2003;31:2742–2751.

52. Alvarez-Lerma F; the ICU-Acquired Pneumonia Study Group. Modification of empiric antibiotic

treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med

1996;22:387–394.

53. Ruhe JJ, Smith N, Bradsher RW, et al. Community-onset methicillin-resistant Staphylococcus aureus

skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis

2007;44:777–784.

54. Schramm GE, Johnson JA, Doherty JA, et al. Methicillin-resistant Staphylococcus aureus sterile-site

infection: the importance of appropriate initial antimicrobial treatment. Crit Care Med

2006;34(8):2069–2074.

55. Chuck EA, Frazee BW, Lambert L, et al. The benefit of empiric treatment for MRSA. J Emerg Med

2010;38(5):567–571.

56. Gorwitz RJ, Jernigan DB, Powers JH, et al. Participants in the CDC-Convened Experts’ Meeting on

Management of MRSA in the Community. Strategies for clinical management of MRSA in the

community: summary of an experts’ meeting convened by the Centers for Disease Control and

Prevention. 2006. Available at: http://www.cdc.gov/mrsa/pdf/mrsa-strategies-expmtgsummary260

http://surgerybook.net/

2006.pdf

57. Sarkar B, Napolitano LM. Necrotizing soft tissue infections. Minerva Chir 2010;65(3):347–362.

58. Sarani B, Strong M, Pascual J, et al. Necrotizing fasciitis: current concepts and review of the

literature. J Am Coll Surg 2009;208(2):279–288.

59. Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis

2007;44(5):705–710.

60. Cainzos M, Gonzalez-Rodriguez FJ. Necrotizing soft tissue infections. Curr Opin Crit Care

2007;13(4):433–439.

61. Yilmazlar T, Ozturk E, Alsoy A, et al. Necrotizing soft tissue infections: APACHE II score,

dissemination, and survival. World J Surg 2007;31(9):1858–1862.

62. Cuschieri J. Necrotizing soft tissue infection. Surg Infect (Larchmt) 2008; 9(6):559–562.

63. Anaya DA, McMahon K, Nathens AB, et al. Predictors of mortality and limb loss in necrotizing soft

tissue infections. Arch Surg 2005;140:151–157.

64. Faraklas I, Stoddard GJ, Neumayer LA, et al. Development and validation of a necrotizing softtissue infection mortality risk calculator using NSQIP. J Am Coll Surg 2013;217(1):153–160.e3;

discussion 160–161.

65. Wong CH, Khin LW, Heng KS, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing

Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit

Care Med 2004;32(7):1535–1541.

66. Su YC, Chen HW, Hong YC, et al. Laboratory risk indicator for necrotizing fasciitis score and the

outcomes. ANZ J Surg 2008;78(11):968–972.

67. Struk DW, Munk PL, Lee MJ, et al. Imaging of soft tissue infections. Radiol Clin North Am

2001;39(2):277–303.

68. Brothers TE, Tagge DU, Stutley JE, et al. Magnetic resonance imaging differentiates between

necrotizing and non-necrotizing fasciitis of the lower extremity. J Am Coll Surg 1998;187:416–421.

69. Malghem J, Lecouvet FE, Omoumi P, et al. Necrotizing fasciitis: contribution and limitations of

diagnostic imaging. Joint Bone Spine 2013;80(2):146–154.

70. Kim KT, Kim YJ, Won Lee J, et al. Can necrotizing infectious fasciitis be differentiated from

nonnecrotizing infectious fasciitis with MR imaging? Radiology 2011;259(3):816–824.

71. Wong CH, Chang HC, Pasupathy S, et al. Necrotizing fasciitis: clinical presentation, microbiology,

and determinants of mortality. J Bone Joint Surg Am 2003;85(8):1454–1460.

72. McHenry CR, Piotrowski JJ, Petrinic D, et al. Determinants of mortality for necrotizing soft-tissue

infections. Ann Surg 1995;221(5):558–565.

73. Elhabash S, Lee L, Farrow B, et al. Characteristics and microbiology of patients presenting with

necrotizing fasciitis. Presented at the Association of VA Surgeons 31st Annual Meeting. Little Rock:

Arkansas; May 10–12, 2007.

74. Lee TC, Carrick MM, Scott BG, et al. Incidence and clinical characteristics of MRSA necrotizing

fasciitis in a large urban hospital. Am J Surg 2007; 194(6):809–812.

75. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by communityassociated MRSA in Los Angeles. N Engl J Med 2005;352(14):1445–1453.

76. Young LM, Price CS. Community-acquired MRSA emerging as an important cause of necrotizing

fasciitis. Surg Infect (Larchmt) 2008;9(4):469–474.

77. Olsen RJ, Burns KM, Chen L, et al. Severe necrotizing fasciitis in a human immunodeficiency viruspositive patient caused by MRSA. J Clin Microbiol 2008;46(3):1144–1147.

78. Dehority W, Wang E, Vernon PS, et al. Community-associated MRSA necrotizing fasciitis in a

neonate. Pediatr Infect Dis J 2006;25(11):1080–1081.

79. Tsai YH, Hsu RW, Huang TJ, et al. Necrotizing soft tissue infections and sepsis caused by Vibrio

vulnificus compared with those caused by Aeromonas species. J Bone Joint Surg Am

2007;89(3):631–636.

80. Tsai YH, Hsu RW, Huang KC, et al. Systemic Vibrio infection presenting as necrotizing fasciitis and

sepsis. A series of 13 cases. J Bone Joint Surg Am 2004;86(11):2497–2502.

81. Minnaganti VR, Patel PJ, Iancu D, et al. Necrotizing fasciitis caused by Aeromonas hydrophila.

Heart Lung 2000;29(4):306–368.

261